Published In

The Laryngoscope

Document Type

Article

Publication Date

4-18-2024

Subjects

Cystic fibrosis, Cystic fibrosis -- Pathophysiology

Abstract

The 22-question SinoNasal Outcome Test (SNOT-22) assesses chronic rhinosinusitis (CRS) severity. We aimed to identify predictors of SNOT-22 score improvement following highly effective modulator therapy (HEMT) initiation and to corroborate the SNOT-22 minimal clinically important difference (MCID) in adults with cystic fibrosis (CF).

Rights

Copyright (c) 2024 The Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

DOI

10.1002/lary.31438

Persistent Identifier

https://archives.pdx.edu/ds/psu/41826

Included in

Psychology Commons

Share

COinS